My Portfolio
+
LINK YOUR PORTFOLIO

Lonza Group AG LON.N-CH:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 5:34 PM CEST
488.90quote price arrow down-7.50 (-1.51%)
Volume
125,911
52 week range
454.60 - 594.80
Loading...
  • Open493.50
  • Day High494.40
  • Day Low484.80
  • Prev Close496.40
  • 52 Week High594.80
  • 52 Week High Date07/23/25
  • 52 Week Low454.60
  • 52 Week Low Date03/23/26

Latest On Lonza Group AG

Key Stats

  • Market Cap34.335B
  • Shares Out70.23M
  • 10 Day Average Volume0.16M
  • Dividend5.00
  • Dividend Yield1.02%
  • Beta1.24

Latest On Lonza Group AG

KEY STATS

  • Open493.50
  • Day High494.40
  • Day Low484.80
  • Prev Close496.40
  • 52 Week High594.80
  • 52 Week High Date07/23/25
  • 52 Week Low454.60
  • 52 Week Low Date03/23/26
  • Market Cap34.335B
  • Shares Out70.23M
  • 10 Day Average Volume0.16M
  • Dividend5.00
  • Dividend Yield1.02%
  • Beta1.24

RATIOS/PROFITABILITY

  • EPS (TTM)-3.93
  • P/E (TTM)-124.40
  • Fwd P/E (NTM)-
  • EBITDA (TTM)3.471B
  • ROE (TTM)10.54%
  • Revenue (TTM)6.531B
  • Gross Margin (TTM)35.35%
  • Net Margin (TTM)13.92%
  • Debt To Equity (MRQ)52.89%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics...
Jean Marc Huet
Independent Chairman of the Board
Wolfgang Wienand Ph.D.
Chief Executive Officer, Member of the Executive Committee
Philippe Deecke
Chief Financial Officer, Member of the Executive Committee
Address
Muenchensteinerstrasse 38
Basel
4002
Switzerland